Skip to main content

Signed · Belgium · Pharma and biotech

Arcturus Therapeutics agrees to acquire myNEO.

Arcturus Therapeutics, based in San Diego, California, signed a definitive agreement on 23 September 2026 to acquire myNEO, an AI-driven drug discovery company in Ghent, Belgium. The deal is subject to customary closing conditions. It was signed on 23 September 2026. It had not completed by 28 October 2026.

SigningDay 100

Signing 23 September 2026

Buyer
Arcturus Therapeutics Holdings Inc. ·San Diego, United States
Target
myNEO Therapeutics ·Ghent, Belgium
Type
Acquisition
Announced
23 September 2026
Signed
23 September 2026
Value
Not disclosed
People
Not stated in the release
Last checked
28 October 2026

The people side in Belgium

Related deals

Get the briefing

Deals into Europe lists public facts with their sources, checked every working day by Octagon Professionals International. Corrections go to info@octagon.nl and are made within one working day. How we track deals.

Enabling organisations to operate across borders with clarity, compliance, and trust.

All deals into Europe